Mark Aspinall-O’Dea

464 total citations
14 papers, 370 citations indexed

About

Mark Aspinall-O’Dea is a scholar working on Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Aspinall-O’Dea has authored 14 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Aspinall-O’Dea's work include Chronic Myeloid Leukemia Treatments (5 papers), Advanced Proteomics Techniques and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mark Aspinall-O’Dea is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Advanced Proteomics Techniques and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mark Aspinall-O’Dea collaborates with scholars based in United Kingdom, United States and Switzerland. Mark Aspinall-O’Dea's co-authors include Eithne Costello, Anthony D. Whetton, Mark Wentworth, Bruno Robert, Alexander V. Ruban, Andrew A. Pascal, Peter Horton, Andrew Pierce, Tessa L. Holyoake and Francesca Pellicano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Mark Aspinall-O’Dea

12 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Aspinall-O’Dea United Kingdom	11	245	80	74	57	52	14	370
Joel W. Thompson United States	7	372 1.5×	73 0.9×	204 2.8×	66 1.2×	119 2.3×	10	662
Katharina Lohrig Germany	8	172 0.7×	54 0.7×	54 0.7×	30 0.5×	52 1.0×	8	319
Yanhong Liu China	14	431 1.8×	88 1.1×	19 0.3×	51 0.9×	101 1.9×	41	590
Nadia Terziyska Germany	10	976 4.0×	47 0.6×	30 0.4×	21 0.4×	29 0.6×	11	1.1k
Jacob P. Turowec Canada	12	468 1.9×	98 1.2×	19 0.3×	14 0.2×	17 0.3×	16	567
Michelle R. Cronk United States	6	327 1.3×	74 0.9×	88 1.2×	8 0.1×	36 0.7×	7	417
Colin H. Lipper United States	12	433 1.8×	50 0.6×	40 0.5×	14 0.2×	81 1.6×	15	646
Nagisa Sakurai United States	11	301 1.2×	47 0.6×	31 0.4×	12 0.2×	25 0.5×	13	412
Chiara Soncini Italy	8	352 1.4×	139 1.7×	68 0.9×	69 1.2×	39 0.8×	9	580
Kévin Adam United States	8	290 1.2×	78 1.0×	15 0.2×	16 0.3×	46 0.9×	11	360

Countries citing papers authored by Mark Aspinall-O’Dea

Since Specialization

Citations

This map shows the geographic impact of Mark Aspinall-O’Dea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aspinall-O’Dea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aspinall-O’Dea more than expected).

Fields of papers citing papers by Mark Aspinall-O’Dea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Aspinall-O’Dea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aspinall-O’Dea. The network helps show where Mark Aspinall-O’Dea may publish in the future.

Co-authorship network of co-authors of Mark Aspinall-O’Dea

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Aspinall-O’Dea. A scholar is included among the top collaborators of Mark Aspinall-O’Dea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Aspinall-O’Dea. Mark Aspinall-O’Dea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Fraser, Kathryn, Frédéric Gervais, Mark Aspinall-O’Dea, et al.. (2025). Applications of Cell-Based Protein Array Technology to Preclinical Safety Assessment of Biological Products. Toxicologic Pathology. 53(1). 31–44. 1 indexed citations

Ratcliffe, Laura E., et al.. (2025). Abstract LB009: Safety profile assessment for IND-enabling studies: Bispecific antibodies and antibody-drug conjugates (ADCs). Cancer Research. 85(8_Supplement_2). LB009–LB009.

Pellicano, Francesca, Lisa Hopcroft, Mary T. Scott, et al.. (2018). hsa-mir183/EGR1–mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood. 131(14). 1532–1544. 33 indexed citations

Crosbie, Philip, Emma J. Crosbie, Mark Aspinall-O’Dea, et al.. (2016). ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing. BMJ Open Respiratory Research. 3(1). e000114–e000114. 17 indexed citations

Pellicano, Francesca, Mary T. Scott, G. Vignir Helgason, et al.. (2014). The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors. Stem Cells. 32(9). 2324–2337. 80 indexed citations

Aspinall-O’Dea, Mark, Andrew Pierce, Francesca Pellicano, et al.. (2014). Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines. Nature Protocols. 10(1). 149–168. 20 indexed citations

Brown, Julia, Claire V. Hutchinson, Mark Aspinall-O’Dea, et al.. (2014). Monocyte‐derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein. European Journal Of Haematology. 93(2). 96–102. 10 indexed citations

Ma, Mengtian, L A Adams, George Garas, et al.. (2014). P430 SELECTIVE INTERNAL RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA: COMBINATION WITH SORAFENIB IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES. Journal of Hepatology. 60(1). S211–S211.

Williamson, Andrew J.K., Andrew Pierce, Ewa Jaworska, et al.. (2013). A Specific PTPRC/CD45 Phosphorylation Event Governed by Stem Cell Chemokine CXCL12 Regulates Primitive Hematopoietic Cell Motility. Molecular & Cellular Proteomics. 12(11). 3319–3329. 16 indexed citations

10.

Pierce, Andrew, Andrew J.K. Williamson, Ewa Jaworska, et al.. (2012). Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation. PLoS ONE. 7(6). e38928–e38928. 15 indexed citations

11.

Tonack, Sarah, Mark Aspinall-O’Dea, John P. Neoptolemos, & Eithne Costello. (2009). Pancreatic Cancer: Proteomic Approaches to a Challenging Disease. Pancreatology. 9(5). 567–576. 27 indexed citations

12.

Tonack, Sarah, Mark Aspinall-O’Dea, Rosalind E. Jenkins, et al.. (2009). A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ. Journal of Proteomics. 73(2). 352–356. 40 indexed citations

13.

Aspinall-O’Dea, Mark & Eithne Costello. (2007). The pancreatic cancer proteome – recent advances and future promise. PROTEOMICS - CLINICAL APPLICATIONS. 1(9). 1066–1079. 15 indexed citations

14.

Aspinall-O’Dea, Mark, Mark Wentworth, Andrew A. Pascal, et al.. (2002). In vitro reconstitution of the activated zeaxanthin state associated with energy dissipation in plants. Proceedings of the National Academy of Sciences. 99(25). 16331–16335. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact